The Waters Corporation (WAT) had a noteworthy engagement at the Leerink Partners Global Healthcare Conference and received significant attention from Leerink and other finance institutions such as JP Morgan, TD Cowen and Stifel, with Leerink, for instance, increasing the price target for the company's stock to $430 and JP Morgan to $390. Meanwhile, the company observed a strong financial performance with Q4 earnings exceeding estimates as well as robust growth reflected in the Q4 2024 earnings call. Despite facing challenges amid certain FX uncertainties, the corporation keeps optimistically assessing its prospects for 2025.
Solid business decisions such as the opening of a precision manufacturing facility in the UK and the acquisition of Wyatt Technology add to the sustained growth of the company. Furthermore, the Waters Corporation unveiled innovative technologies such as the ElectroForce Apex 1 instrument, Waters TGA Smart-Seal Pans, and Waters ACQUITY QDa II Mass Detector. Looming forex-derived uncertainty has led to anticipations of lower profits, but the company's annual earnings sync with analysts' forecasts and its shares continue to rise, hitting a 52-week high at $420.32.
Waters Corp WAT News Analytics from Tue, 01 Feb 2022 08:00:00 GMT to Sat, 08 Mar 2025 08:33:16 GMT - Rating 8 - Innovation 5 - Information 7 - Rumor -3
